MARKET

SNN

SNN

Smith & Nephew
NYSE

Real-time Quotes | Nasdaq Last Sale

31.98
+0.43
+1.36%
After Hours: 31.98 0 0.00% 16:10 05/20 EDT
OPEN
31.94
PREV CLOSE
31.55
HIGH
32.01
LOW
31.49
VOLUME
551.11K
TURNOVER
0
52 WEEK HIGH
44.47
52 WEEK LOW
29.40
MARKET CAP
13.95B
P/E (TTM)
26.81
1D
5D
1M
3M
1Y
5Y
Smith & Nephew (LON:SN.) stock falls 5.1% in past week as three-year earnings and shareholder returns continue downward trend
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
Simply Wall St. · 05/11 08:31
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
MT Newswires · 04/29 01:06
Smith & Nephew reports Q1 results
Smith & Nephew press release (NYSE:SNN): Q1 Revenue of $1.31B (+3.3% Y/Y) beats by $40M. Sports Medicine & ENT revenue up 8.6% underlying; Advanced Wound Management revenue up 8.0% underlying; Orthopaedics
Seekingalpha · 04/28 19:31
Smith & Nephew Posts Q1 Sales Growth As Elective Procedures Rebound
Benzinga · 04/28 19:21
11 Best UK Stocks to Buy Now
In this article, we discuss 11 best UK stocks to buy now. If you want to see some more stocks from our selection, click 5 Best UK Stocks to Buy Now. Market experts and analysts from advisory firms believe that the underlying economic recovery after the pan...
Insider Monkey · 04/11 20:29
Form 8.3 - Sanne Group plc
LONDON, April 11, 2022-- FORM 8.3
Business Wire · 04/11 14:25
Form 8.3 - SANNE GROUP PLC
NEW YORK, April 07, 2022--
Business Wire · 04/07 12:30
Should Weakness in Smith & Nephew plc's (LON:SN.) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
With its stock down 6.1% over the past three months, it is easy to disregard Smith & Nephew (LON:SN.). However, stock...
Simply Wall St. · 04/04 15:50
More
No Data
Learn about the latest financial forecast of SNN. Analyze the recent business situations of Smith & Nephew through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

75.00%Strong Buy
0.00%Buy
25.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average SNN stock price target is 38.47 with a high estimate of 40.00 and a low estimate of 37.00.
High40.00
Average38.47
Low37.00
Current 31.98
EPS
Actual
Estimate
0.380.751.131.50
2020/06
2020/12
2021/06
2021/12
2022/06
Institutional Holdings
Institutions: 353
Institutional Holdings: 44.75M
% Owned: 10.26%
Shares Outstanding: 436.19M
TypeInstitutionsShares
Increased
71
4.30M
New
29
945.00K
Decreased
66
5.56M
Sold Out
36
711.24K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.35%
Healthcare Equipment & Supplies
+0.36%
Key Executives
Non-Executive Chairman/Independent Director
Roberto Quarta
Chief Executive Officer
Deepak Nath
Chief Financial Officer/Executive Director
Anne-Francoise Nesmes
Corporate Executive
Brad Cannon
Corporate Executive
Peter Coenen
Corporate Executive
Myra Eskes
Corporate Executive
Simon Fraser
Corporate Executive
Vasant Padmanabhan
Chief Human Resource Officer
Elga Lohler
Other
Phil Cowdy
Secretary
Susan Swabey
Non-Executive Director
Jo Hallas
Non-Executive Independent Director
Erik Engstrom
Non-Executive Independent Director
Robin Freestone
Non-Executive Independent Director
John Ma
Non-Executive Independent Director
Katarzyna Mazurhofsaess
Non-Executive Independent Director
Rick Medlock
Non-Executive Independent Director
Marc Owen
Non-Executive Independent Director
Angie Risley
Non-Executive Independent Director
Bob White
No Data
No Data
About SNN
Smith & Nephew plc is a medical technology company. The Company is engaged in designing and manufacturing technology. It supports healthcare professionals to return their patients to health and mobility by helping them to perform. It serves its customers through global franchises, which includes Orthopaedics, Sports Medicine and Ear, Nose and Throat (ENT) and Advanced Wound Management. The Orthopaedics includes a range of Hip and Knee Implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that allow surgeons, and Trauma products used to stabilize severe fractures and correct bone deformities. Its Sports Medicine and ENT businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a set of products to meet clinical needs, to help healthcare professionals reduce the human and economic consequences of wounds.

Webull offers kinds of Smith & Nephew plc (ADR) stock information, including NYSE:SNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNN stock methods without spending real money on the virtual paper trading platform.